UNSPSC 51284306: Thiamphenicol glycinate

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C14H18Cl2N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5H94CY6V6, chemically known as glycine, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulfonyl)phenyl)propyl ester, but more generally known as thiamphenicol glycinate, which bears US NIH Compound Identifier 115817.

European Medicines Agency schedules thiamphenicol glycinate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10970MIG. Most nations, for tariff purposes, schedule thiamphenicol glycinate under HS 29414000. SMILES: CS(=O)(=O)C1CCC(CC1)[C@H]([C@@H](COC(=O)CN)NC(=O)C(CL)CL)O.

UNSPSC 51284306 Thiamphenicol glycinate is a Commodity code that in practice captures pharmaceuticals and medical supplies procured by state and local health agencies, emergency-response departments, and cooperative purchasing alliances. Recent solicitations under this code show state and local governments buying naloxone and drug deactivation systems for community health programs, medical and first aid supplies for fire-rescue operations, and generic pharmaceuticals and over-the-counter products through multi-state cooperative purchasing agreements. The issuing bodies span county health departments, municipal fire and rescue divisions, state health and human services agencies, and multi-state cooperative purchasing organizations. The scope of work ranges from individual emergency-response consumables and specialty pharmaceuticals to bulk generic medication supply programs serving multiple jurisdictions through authorized wholesale distributors.

Procurement activity under the code appears concentrated in Florida and Minnesota, with additional activity in Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, with a response deadline of July 26, 2023; the City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with a March 13, 2026 response deadline and an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount not to exceed $10,000. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities across Minnesota and Oregon, with proposals due March 26, 2026 and an evaluation weighting heavily toward price competitiveness at 75 percent. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, an exploratory procurement mechanism to inform future formal solicitations.